The Munich vulnerability study on affective disorders: premorbid neuroendocrine profile of affected high-risk probands.
One of the most characteristic alterations in depression is a disturbed regulation of the hypothalamic-pituitary-adrenocortical (HPA) system. A function test combining the pre-treatment of 1.5 mg dexamethasone (DEX) with a challenge of 100 microg corticotropin-releasing hormone (CRH) reveals a pathological increase in the adrenocorticotropin and cortisol release in patients with major depression. These changes partially persist after successful treatment with remission and therefore, might represent trait or vulnerability markers. To further address this question, we were investigating the premorbid neuroendocrine profile of 74 healthy high-risk probands (HRPs) with a positive family history for affective disorders. The aim was to identify premorbid vulnerability factors. During the observation period, 19 HRPs developed an affective disorder. Their premorbid DEX/CRH test results were compared with 19 age- and sex matched controls. No significant differences could be observed between these two groups. Our results suggest that a dysregulated HPA system indicated by this function test can rather be regarded as a neurobiological scar developing during the course of affective disorders.
Ising
M
M
Max Planck Institute of Psychiatry, Kraeplinstrasse 10, D-80804 München, Germany. ising@mpipsykl.mpg.de
Lauer
C J
CJ
Holsboer
F
F
Modell
S
S
D000328:Adult; D016022:Case-Control Studies; D003346:Corticotropin-Releasing Hormone; D003907:Dexamethasone; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology*; D008297:Male; D019964:Mood Disorders / Q000175:diagnosis / Q000209:etiology* / Q000235:genetics*; D010375:Pedigree; D010913:Pituitary-Adrenal System / Q000502:physiology*; D011237:Predictive Value of Tests; D012016:Reference Values; D012307:Risk Factors; D012680:Sensitivity and Specificity
D005938:Glucocorticoids; D003907:Dexamethasone; D003346:Corticotropin-Releasing Hormone